Psychosomatic treatment options for functional post-covid syndrome: a randomized trial of open-label placebos and breathing exercises.

Not Applicable

Recruiting

• Conditions: PostCovid19; U09.9; Post COVID-19 condition, unspecified

• Registration Number: DRKS00028488
• Lead Sponsor: Klinik für Psychosomatische Medizin und Psychotherapie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-10-07
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Patients with functional post-covid syndrome (persisting symptoms > 3 months after covid-19 disease without a clear organic cause)

Exclusion Criteria

organic causes of symptoms after covid-19 disease; implanted pacemaker; diagnosed hyperventilation syndrome; lactose intolerance; diagnosed allergy to any of the placebo pills' ingredients; pregnancy and lactation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fatigue (assesed via questionnaire: Fatigue Scale for Motor and Cognitive Functions; FSMC)

Secondary Outcome Measures

Name	Time	Method
Quality of life (SF-36), depression (PHQ-9), anxiety (GAD-7), somatic symptoms (PHQ-15), service receipt (CSSRI), <br>IL-6, IL-1b, high-sensitive CRP, TNFalpha, D-Dimer, differentiated white blood cell count.